Mobile Health & Mindfulness for Young Adult Cancer Survivors
Trial Summary
What is the purpose of this trial?
This trial tests a mobile health program using a Fitbit and an app to help young adult cancer survivors stay active. The program includes coaching, support from a buddy, and mindfulness exercises. It aims to improve their quality of life by increasing physical activity and reducing symptoms like fatigue and anxiety.
Do I need to stop my current medications to join the trial?
The trial does not specify whether you need to stop taking your current medications. However, it mentions that participants may still be undergoing endocrine or hormone therapies.
What data supports the effectiveness of the treatment Mobile Health & Mindfulness for Young Adult Cancer Survivors?
Is the Mobile Health & Mindfulness intervention safe for young adult cancer survivors?
How is the 'Mobile Health & Mindfulness for Young Adult Cancer Survivors' treatment different from other treatments for young adult cancer survivors?
This treatment is unique because it combines mobile health technology with mindfulness training and peer support to promote physical activity and well-being among young adult cancer survivors. It integrates digital coaching and social support components, which are not typically part of standard cancer survivor care, making it a novel approach to improving quality of life and physical activity maintenance.125910
Research Team
Siobhan M Phillips, PhD, MPH
Principal Investigator
Northwestern University
David E Victorson, PhD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for young adult cancer survivors aged 18-39, who are at least three months post-primary treatment but may still be on hormone therapies. They should engage in less than 60 minutes of moderate to vigorous physical activity weekly, own a smartphone with internet access, and speak English fluently. Participants need a 'Buddy' willing to support them and share Fitbit data. Pregnant individuals or those in other trials cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment and Randomization
Participants complete baseline assessments and are randomized into intervention groups
Intervention
Participants engage in a 12-week mHealth physical activity intervention with various components such as e-coaching, buddy system, and mindfulness training
Follow-up
Participants maintain their MVPA during the 12-week follow-up period with access to all materials
Treatment Details
Interventions
- Buddy (Behavioural Intervention)
- Core Intervention (Behavioural Intervention)
- E-Coach (Behavioural Intervention)
- General Mindfulness Training (Behavioural Intervention)
- MVPA-Specific Mindfulness Training (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Dr. Jeffrey Sherman
Northwestern University
Chief Medical Officer
MD from Northwestern University
Dr. Alicia Löffler
Northwestern University
Chief Executive Officer since 2010
PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School
Wake Forest University Health Sciences
Collaborator
Dr. L. Ebony Boulware
Wake Forest University Health Sciences
Chief Medical Officer since 2022
MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health
Dr. Julie Ann Freischlag
Wake Forest University Health Sciences
Chief Executive Officer since 2020
BS from University of Illinois, MD from Rush University